The financing was led by Amzak Health, according to a Jan. 31 news release. Money will go towrd the company’s investigational device exemption 2-level clinical trial. The trial will evaluate the disc at two contiguous levels compared to anterior cervical discectomy and fusion.
Through the investment Joyce Erony of Amzak Health also joined Synergy’s board of directors.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
